All In Biotech

Drug Trial Radar · NCT00528970

A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of Post Operative Ileus After Ventral Hernia Repair

Last checked: Nov 19, 2026Latest source record: Sep 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 374 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

374

Actual

Start

Oct 17, 2007

Primary completion

Feb 5, 2008

Study completion Feb 5, 2008

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
Collaborators
Progenics Pharmaceuticals, Inc.
First posted
Sep 14, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety and efficacy of two different dose regimens (12 milligrams \[mg\] and 24 mg) of IV MOA-728 versus placebo in shortening the time to return of bowel function in participants receiving opioid analgesia administered via patient-controlled anesthesia (PCA), and who had undergone repair of large (greater than or equal to \[≥\]10 centimeters) ventral hernias with or without a mesh prosthesis via laparotomy or laparoscopy.

Conditions

  • Ileus

Interventions

  • MOA-728Drug

    MOA-728 will be administered per the dose and schedule specified in the arm.

  • PlaceboDrug

    Placebo matching to MOA-728 will be administered per the schedule specified in the arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to First Bowel MovementTime frame: Day 1 (From the time of end of surgery [that is; from the first dose of study drug administration]) up to Day 10

Locations

106 sites in 11 countries. Site status is shown where the registry gives one.

  • Site not named

    Benton, Arkansas

  • Site not named

    Colton, California

  • Site not named

    Laguna Hills, California

  • Site not named

    Loma Linda, California

  • Site not named

    Long Beach, California

  • Site not named

    Los Angeles, California

  • Site not named

    Orange, California

  • Site not named

    San Jose, California

  • Site not named

    Santa Barbara, California

  • Site not named

    Denver, Colorado

  • Site not named

    Denver, Colorado

  • Site not named

    Inverness, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Melbourne, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Naples, Florida

  • Site not named

    Orlando, Florida

  • Site not named

    Pensacola, Florida

  • Site not named

    Tampa, Florida

  • Site not named

    Peoria, Illinois

  • Site not named

    Des Moines, Iowa

  • Site not named

    Kansas City, Kansas

  • Site not named

    Lexington, Kentucky

  • Site not named

    Baltimore, Maryland

  • Site not named

    Boston, Massachusetts

  • Site not named

    Boston, Massachusetts

  • Site not named

    Springfield, Massachusetts

  • Site not named

    Ann Arbor, Michigan

  • Site not named

    Detroit, Michigan

  • Site not named

    Flint, Michigan

  • Site not named

    Jackson, Mississippi

  • Site not named

    Columbia, Missouri

  • Site not named

    Omaha, Nebraska

  • Site not named

    Omaha, Nebraska

  • Site not named

    New Brunswick, New Jersey

  • Site not named

    Albuquerque, New Mexico

  • Site not named

    Albany, New York

  • Site not named

    New York, New York

Showing 40 of 106 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.